• Skip to primary navigation
  • Skip to main content
  • Skip to footer

IHI Montana Foundation

Improving Patient Care Through Education & Research

  • Home
  • About
    • About Us
    • Our History
    • Our Logo
    • Who We Are
    • Staff
    • Board of Directors
    • In The News
  • Heart Education
  • Clinical Research
  • Faculty
  • Donate
  • Contact

ABSORB IV

Clinical Area
Interventional Cardiology/Investigational Devices

Study Title
ABSORB IV

Purpose of Research
The purpose of this study is to evaluate the long-term outcomes of the Absorb BVS (Bioresorbable Vascular Scaffold) compared to XIENCE in the treatment of subjects with ischemic heart disease caused by up to three target de novo native coronary artery lesions, with a maximum of two target lesions per epicardial vessel. It is a randomized trial of 3000 subjects at 132 locations.

Participant Description
Subjects with ischemic heart disease caused by up to three de novo coronary artery lesions in with a maximum of two target lesions per epicardial vessel.

Principal Investigator
James T. Maddux, MD

Study Coordinator
Kelli Hofffman

Study Status
Follow-up

Footer

Address: 500 W. Broadway – Suite 350 Missoula, MT 59802
Phone: 406 329 5668

Copyright © 2021 IHI Montana Foundation
Home ยท Log in